Fox Chase Cancer Center News

PHILADELPHIA (May 19, 2016) — Researchers from Fox Chase Cancer Center and Temple University have developed a cellular programming approach that creates alloreactive T cells that are able to eliminate leukemic cells without causing graft versus host disease (GvHD).

PHILADELPHIA (May 4, 2016) — May is Skin Cancer Awareness Month, and chances are you will be spending more time outdoors. Fox Chase Cancer Center advises people to protect their skin from sun damage and become familiar with the early signs of skin cancer.

PHILADELPHIA (May 2, 2016) — Faculty, staff, volunteers, patients, survivors and their families and friends will come together as members of the Fox Chase Cancer Center–Temple Health team at AMP UP! Move to End Bladder Cancer’s annual 2-mile walk on Saturday, May 14, 2016.

PHILADELPHIA (May 1, 2016) — Many patients with breast or ovarian cancer initially benefit from DNA-damaging chemotherapies, but it has not been clear why these treatments lose effectiveness over time. In a new study, Fox Chase Cancer Center researchers showed that patients with mutations affecting a specific portion of the BRCA1 gene were susceptible to a new pathway of resistance to DNA-damaging drugs, including PARP inhibitors and platinum compounds.

PHILADELPHIA (April 25, 2016) — Faculty, staff, volunteers, patients, survivors, and their families and friends will come together as members of the Fox Chase Cancer Center-Temple Health team at Susan G. Komen Philadelphia’s 26th Annual Race for the Cure on Mother’s Day — Sunday, May 8, 2016.

PHILADELPHIA (April 22, 2016) – Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options, will be on May 7, 2016, at the Sheraton Philadelphia Downtown Hotel in Philadelphia, Pennsylvania.

Scanning over 14,000 neighborhood variables from the U.S. Census for associations with prostate cancer aggressiveness, the study identified 17 neighborhood variables that were most significantly associated with advanced prostate cancer in white men.